Several risk factors were finally identified and required attention, including lymph node metastasis at pN2a-b, positive level of CEA, and additional distant metastases (lung, liver, or bone). The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.